Adacolumn.com
JIMRO
Top page
Press Release
Method
Preclinical
Clinical trial
Quality of life
Package insert
Literature
Case Report
Inquire
Associated companies
JIMRO.com

Interview Report > -General Information-


  1. How many ulcerative colitis (UC) and Crohn’s disease (CD) patients are there in Sweden?

    There are approximately 45,000 - 55,000 UC patients, and 35,000 - 40,000 CD patients in Sweden. If all forms of IBD including proctitis, microscopic and indeterminate colitis are included, the IBD patient number is perhaps 100,000. Generally, the prevalence (all patients) of IBD in Sweden is approximately 1% of the population. The prevalence in Sweden is about 10 times more than Japan (0.1%). However, the prevalence is increasing sharply in Japan now whereas in Sweden, it is stable high. If we look at the numbers of IBD patients in Sweden around 1945, the prevalence was also increasing sharply at that time. A similar pattern was seen in the U.S., U.K., Canada and now in Japan. This is probably due to the dietary and environmental factors. The incidence (new patients) of IBD in Sweden is 10-12/100,000 for UC including proctitis, and 5-7/100,000 for CD.


  2. What are the male/female ratios for UC and CD in Sweden?

    In Sweden, UC is more common among males. This is probably due to smoking. Smoking seems to protect from UC. We almost never see smokers among the UC population. On the other hand, CD is more common among females, and smoking seems to promote CD. Many female CD patients are heavy smokers. Smoking is also related to the prognosis in CD. The disease is much worse if a patient continues smoking. Patients with CD who stop smoking, there are fewer relapses and a less severe course of disease.
    Many papers have reported that appendectomy protects against UC. So, smoking and appendectomy (due to appendicitis) seem to protect against UC but there seem to be no particular protection against CD.


  3. What are the mean ages when UC and CD are first diagnosed?

    The peak age range for first diagnosed ages for IBD is between 15-30 years, which is similar to Japan.

  4. What do you think will be the trend of CD and UC in term of disease incidence?

    In UC, the first diagnosed age seems to be getting older, and that of CD seems to get younger. The prevalence of IBD is thought to be increasing all the time. In Sweden, the prevalence of IBD will perhaps increase to more than 1% in the next 20 years. Similarly, IBD prevalence in Japan will perhaps reach 1%, because the time lag between Sweden and Japan is approximately 20 years. IBD will eventually be a more common disease group, like rheumatoid arthritis and hypertension in Japan.

    Top
    Treatment for UC and CD in Sweden


    Interview Report